Patents for A61P 33 - Antiparasitic agents (21,787)
04/1994
04/28/1994CA2147378A1 Vaccine containing a thiol protease
04/28/1994CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof
04/28/1994CA2145203A1 Amino acid conjugates of cyclohexapeptidyl amines
04/27/1994EP0594291A1 Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
04/26/1994US5306708 Antibiotic agent
04/26/1994CA1328868C Substituted 1,2,4-triazinediones, processes for their preparation and their use
04/20/1994CN1085554A 3-aryl-pyrone derivatives
04/13/1994EP0591781A1 Substituted carbamoylpyrazolines, process for their preparation and their use as pesticides
04/13/1994EP0591303A1 Methods and compositions for treating malaria and other diseases
04/12/1994US5302727 Multidrug resistance modifying dithianes
04/06/1994EP0590425A1 Control of fish parasites
04/06/1994EP0590415A2 1,2,4-Oxadiazole derivatives for controlling endoparasites
04/05/1994US5300491 Administering a divalent metal salt of bacitracins as antiprotozoa agents
03/1994
03/31/1994WO1994006280A1 Inhibitors of metazoan parasite proteases
03/30/1994CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/29/1994US5298495 Partricin derivatives
03/23/1994EP0588430A1 (S)-(+)-Hydroxychloroquine
03/23/1994EP0588137A1 3-Aryl-2-pyranone derivatives
03/17/1994WO1994005690A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans
03/17/1994WO1994005652A1 4,5-dicyanoimidazole derivatives and pesticidal compositions containing them
03/17/1994CA2143417A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans
03/17/1994CA2120341A1 4,5-dicyanoimidazole derivatives and pesticidal compositions containing them
03/16/1994CN1083818A Antiparasitic agents
03/16/1994CA2104903A1 (s)-(+)-hydroxychloroquine
03/11/1994CA2105614A1 3-aryl-pyrone derivatives
03/09/1994EP0585681A2 Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections
03/09/1994EP0585337A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
03/08/1994US5292647 Strain of streptomyces for producing avermectins and processes therewith
03/03/1994WO1994004676A1 Stress protein epitopes
03/03/1994WO1994004172A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
03/03/1994CA2142839A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
03/02/1994EP0585080A2 Oxygenated heterocyclic compounds, pharmaceutical compositions containing them
03/02/1994CN1083048A Heterocyclic compounds
03/01/1994US5290804 Anthelmintic milbemycin analogs of novel microorganisms
03/01/1994CA1327317C Pharmaceutical composition containing 1,2,4-trioxane
02/1994
02/23/1994CN1023858C Pesticide composition containing macrolide compound and its making method
02/22/1994US5288845 Eimeria necatrix 16s rDNA probes
02/22/1994US5288710 Stable salts of 4"-deoxy-4"-epi-methylamino avermectin Bla/Blb
02/22/1994CA2104551A1 Oxygenated heterocyclic compounds
02/17/1994WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine
02/17/1994WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof
02/17/1994CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine
02/03/1994WO1994002498A1 Hybrid oligonucleotide phosphorothioates
02/03/1994WO1994002470A1 Pesticidal pyrimidine compounds
02/03/1994WO1994002469A1 Pyrimidine compounds used in the therapy
02/03/1994WO1994002169A1 Vaccines against metazoan parasites
02/03/1994CA2140673A1 Vaccines against metazoan parasites
02/03/1994CA2140346A1 Pesticidal pyrimidine compounds
02/03/1994CA2140018A1 Pyrimidine compounds used in the therapy
01/1994
01/26/1994EP0580185A1 Medicaments
01/25/1994US5281588 Treatment of trypanosomia parasites
01/25/1994CA1326453C Pharmaceutical composition containing pentamidine
01/25/1994CA1326446C Substance or pharmaceutical or cosmetic composition inhibition or destroying at least one unicellular living creature and/or at least one virus, drug or product containing such a substance, process of manufacture of such substance, chemical compound included in such substance, and process of inhibition or destruction of at least one...
01/20/1994WO1994001432A1 Imidazole derivatives
01/20/1994CA2116455A1 Imidazole derivatives
01/19/1994EP0579280A1 Pesticidal method using N-phenylpyrazoles
01/19/1994EP0578733A1 Use of riboflavin in the treatment of hiv, herpes virus, retinitis pigmentosa and malaria related deseases
01/12/1994EP0578521A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them
01/12/1994EP0578342A2 Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor
01/11/1994US5278298 Eimeria brunetti 16s rDNA probes
01/11/1994US5277907 Regulation of the immune system
01/06/1994WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof
01/06/1994CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof
12/1993
12/29/1993EP0576251A1 Substituted 1,2,4-triazine-3,5-dione derivatives and drug compositions containing them, particularly for coccidiosis treatment
12/29/1993CN1023318C Process for preparing 1-hydroxyalkyl-5-nitro imidazoles
12/26/1993CA2098650A1 Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
12/23/1993WO1993025543A2 Enniatines and enniatine derivates used to control endoparasites
12/23/1993CA2137679A1 Use of cyclic depsipeptides having 18 ring atoms for combating endoparasites, new cyclic depsipeptides having 18 ring atoms, and processes for their preparation
12/19/1993CA2098655A1 Bradykinin antagonist peptidic derivatives, process for preparing them and phamaceutical compositions containing same
12/16/1993DE4317458A1 Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung Use of cyclic depsipeptides having 18 ring atoms for the control of endoparasites, to novel cyclic depsipeptides having 18 ring atoms, and processes for their preparation
12/15/1993EP0573883A1 Utilization of 3 substituted aryl-5-alkyl-isoxazole-4-carboxylic acid derivatives against endoparasites new 3-substituted aryl-5-alkyl-isoxazole-4-carboxylic acid derivatives and process for their preparation
12/15/1993EP0573628A1 New a83543 compounds and process for production thereof
12/14/1993CA1325208C Antiparasitic agents
12/14/1993CA1325207C Insecticides and parasiticides
12/09/1993WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor
12/09/1993WO1993024451A1 Desferrioxamine-b salts and their use as orally effective iron chelators
12/09/1993WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993WO1993024130A1 Drug containing (-)-metriphonate
12/09/1993WO1993024002A1 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets
12/09/1993CA2306952A1 Method for removing dental plaque
12/09/1993CA2136548A1 Metrifonate-containing medicament
12/09/1993CA2135394A1 Desferrioxamine-b salts and their use as orally effective iron chelators
12/08/1993EP0572537A1 Cytokine inhibitors
12/02/1993DE4217396A1 Metrifonat enthaltendes Arzneimittel Metrifonate drug containing
11/1993
11/30/1993US5266689 Eimeria maxima 165 rDNA probes
11/25/1993WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
11/25/1993WO1993023077A1 Vaccine for susceptible hosts against nonadapted parasites
11/25/1993CA2135512A1 Vaccine for susceptible hosts against nonadapted parasites
11/25/1993CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
11/24/1993EP0570514A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom
11/24/1993EP0570489A1 LIVER-STAGE-SPECIFIC PEPTIDE SEQUENCES OF $i(P. FALCIPARUM) BEARING EPITOPES CAPABLE OF STIMULATING THE T LYMPHOCYTES
11/23/1993US5264216 Treatment of bacterial infections
11/16/1993US5262400 Antiparasitic and anthelmintic
11/15/1993CA2095404A1 Purification and characterization of a csvtcg-specific tumor cell adhesion receptor
11/11/1993WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/11/1993WO1993022307A1 Avermectin difluoro derivatives
11/11/1993WO1993020103A3 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification
11/09/1993CA1324155C Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/02/1993US5258373 Synergistic mixture of sulfadimethoxine, ormetoprim and frenolicin-b